StockNews.com lowered shares of Integra LifeSciences (NASDAQ:IART – Free Report) from a buy rating to a hold rating in a report issued on Friday. Several other analysts have also recently weighed in on the company. Jefferies Financial Group upgraded Integra LifeSciences from a hold rating to a buy rating and reduced their price target for […]
Integra LifeSciences (NASDAQ:IART – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday. IART has been the topic of several other reports. JMP Securities cut their price target on shares of Integra LifeSciences from $65.00 […]
Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) was the recipient of a large decrease in short interest in October. As of October 15th, there was short interest totalling 2,390,000 shares, a decrease of 5.5% from the September 30th total of 2,530,000 shares. Approximately 3.4% of the shares of the stock are sold short. […]
Integra LifeSciences (NASDAQ:IART – Free Report) had its price target reduced by Truist Financial from $41.00 to $39.00 in a report issued on Thursday, Benzinga reports. They currently have a hold rating on the life sciences company’s stock. Several other equities analysts have also issued reports on the stock. JMP Securities lowered their target price […]
Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report)’s share price gapped down before the market opened on Wednesday following a dissappointing earnings announcement. The stock had previously closed at $37.20, but opened at $35.04. Integra LifeSciences shares last traded at $35.02, with a volume of 115,455 shares trading hands. The life sciences company reported […]